Cargando…
Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362263/ https://www.ncbi.nlm.nih.gov/pubmed/34409396 http://dx.doi.org/10.1016/j.jdin.2021.06.001 |
| _version_ | 1783738127482880000 |
|---|---|
| author | Georgakopoulos, Jorge R. Felfeli, Tina Drucker, Aaron M. Jo, Christine E. Piguet, Vincent Yeung, Jensen |
| author_facet | Georgakopoulos, Jorge R. Felfeli, Tina Drucker, Aaron M. Jo, Christine E. Piguet, Vincent Yeung, Jensen |
| author_sort | Georgakopoulos, Jorge R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8362263 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83622632021-08-17 Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study Georgakopoulos, Jorge R. Felfeli, Tina Drucker, Aaron M. Jo, Christine E. Piguet, Vincent Yeung, Jensen JAAD Int Letter Elsevier 2021-07-31 /pmc/articles/PMC8362263/ /pubmed/34409396 http://dx.doi.org/10.1016/j.jdin.2021.06.001 Text en © 2021 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter Georgakopoulos, Jorge R. Felfeli, Tina Drucker, Aaron M. Jo, Christine E. Piguet, Vincent Yeung, Jensen Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study |
| title | Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study |
| title_full | Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study |
| title_fullStr | Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study |
| title_full_unstemmed | Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study |
| title_short | Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study |
| title_sort | two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: a real-world canadian multicenter retrospective study |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362263/ https://www.ncbi.nlm.nih.gov/pubmed/34409396 http://dx.doi.org/10.1016/j.jdin.2021.06.001 |
| work_keys_str_mv | AT georgakopoulosjorger twoyearefficacysafetyanddrugsurvivalofdupilumabforatopicdermatitisarealworldcanadianmulticenterretrospectivestudy AT felfelitina twoyearefficacysafetyanddrugsurvivalofdupilumabforatopicdermatitisarealworldcanadianmulticenterretrospectivestudy AT druckeraaronm twoyearefficacysafetyanddrugsurvivalofdupilumabforatopicdermatitisarealworldcanadianmulticenterretrospectivestudy AT jochristinee twoyearefficacysafetyanddrugsurvivalofdupilumabforatopicdermatitisarealworldcanadianmulticenterretrospectivestudy AT piguetvincent twoyearefficacysafetyanddrugsurvivalofdupilumabforatopicdermatitisarealworldcanadianmulticenterretrospectivestudy AT yeungjensen twoyearefficacysafetyanddrugsurvivalofdupilumabforatopicdermatitisarealworldcanadianmulticenterretrospectivestudy |